PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,000 | +27.8% | 52,451 | +33.5% | 0.00% | – |
| Q2 2023 | $712,000 | -55.8% | 39,296 | -35.2% | 0.00% | – |
| Q1 2023 | $1,612,000 | +276.6% | 60,625 | +173.6% | 0.00% | – |
| Q4 2022 | $428,000 | +3.1% | 22,159 | +11.8% | 0.00% | – |
| Q3 2022 | $415,000 | +20650.0% | 19,820 | +7268.0% | 0.00% | – |
| Q2 2022 | $2,000 | -81.8% | 269 | -83.8% | 0.00% | – |
| Q1 2022 | $11,000 | -84.5% | 1,665 | -68.6% | 0.00% | – |
| Q4 2021 | $71,000 | +77.5% | 5,295 | +121.5% | 0.00% | – |
| Q3 2021 | $40,000 | -16.7% | 2,390 | +45.1% | 0.00% | – |
| Q2 2021 | $48,000 | -42.9% | 1,647 | -22.6% | 0.00% | – |
| Q1 2021 | $84,000 | +1580.0% | 2,128 | +829.3% | 0.00% | – |
| Q4 2020 | $5,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |